BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 17565216)

  • 1. Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
    Ylikoski R; Jokinen H; Andersen P; Salonen O; Madureira S; Ferro J; Barkhof F; van der Flier W; Schmidt R; Fazekas F; Scheltens P; Waldemar G; Salvadori E; Pantoni L; Inzitari D; Erkinjuntti T;
    Dement Geriatr Cogn Disord; 2007; 24(2):73-81. PubMed ID: 17565216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.
    Madureira S; Verdelho A; Ferro J; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    Neuroepidemiology; 2006; 27(2):101-16. PubMed ID: 16943684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.
    Pyo G; Elble RJ; Ala T; Markwell SJ
    Alzheimer Dis Assoc Disord; 2006; 20(1):16-22. PubMed ID: 16493231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
    Doddy RS; Massman PJ; Mawad M; Nance M
    Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls.
    Graham DP; Cully JA; Snow AL; Massman P; Doody R
    Alzheimer Dis Assoc Disord; 2004; 18(4):236-40. PubMed ID: 15592137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study.
    Madureira S; Verdelho A; Moleiro C; Ferro JM; Erkinjuntti T; Jokinen H; Pantoni L; Fazekas F; Van der Flier W; Visser M; Waldemar G; Wallin A; Hennerici M; Inzitari D
    Dement Geriatr Cogn Disord; 2010; 29(4):325-34. PubMed ID: 20389074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
    Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TE4D-Cog: a new test for detecting early dementia in English-speaking populations.
    Mahoney R; Johnston K; Katona C; Maxmin K; Livingston G
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1172-9. PubMed ID: 16315149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog) in an Icelandic elderly population.
    Hannesdóttir K; Snaedal J
    Nord J Psychiatry; 2002; 56(3):201-6. PubMed ID: 12079572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.
    Gillen TE; Gregg KM; Yuan H; Kurth MC; Krishnan KR
    Psychopharmacol Bull; 2001; 35(2):83-96. PubMed ID: 12397889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study.
    Jokinen H; Kalska H; Ylikoski R; Madureira S; Verdelho A; Gouw A; Scheltens P; Barkhof F; Visser MC; Fazekas F; Schmidt R; O'Brien J; Hennerici M; Baezner H; Waldemar G; Wallin A; Chabriat H; Pantoni L; Inzitari D; Erkinjuntti T;
    Cerebrovasc Dis; 2009; 27(4):336-44. PubMed ID: 19218799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive function impairment in community elderly subjects with questionable dementia.
    Lam LC; Lui VW; Chiu HF; Chan SS; Tam CW
    Dement Geriatr Cogn Disord; 2005; 19(2-3):86-90. PubMed ID: 15572877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.
    Verdelho A; Madureira S; Moleiro C; Ferro JM; Santos CO; Erkinjuntti T; Pantoni L; Fazekas F; Visser M; Waldemar G; Wallin A; Hennerici M; Inzitari D;
    Neurology; 2010 Jul; 75(2):160-7. PubMed ID: 20625169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
    Meyer JS; Huang J; Chowdhury MH
    J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study.
    Poggesi A; Pracucci G; Chabriat H; Erkinjuntti T; Fazekas F; Verdelho A; Hennerici M; Langhorne P; O'Brien J; Scheltens P; Visser MC; Crisby M; Waldemar G; Wallin A; Inzitari D; Pantoni L;
    J Am Geriatr Soc; 2008 Sep; 56(9):1638-43. PubMed ID: 18691285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.